NASDAQ:GBT - Global Blood Therapeutics Price Target & Analyst Ratings

Sign in or create an account to add this stock to your watchlist.
$43.23 +0.46 (+1.08 %)
(As of 12/12/2018 04:00 PM ET)
Previous Close$42.77
Today's Range$42.00 - $43.88
52-Week Range$30.15 - $68.05
Volume794,800 shs
Average Volume1.12 million shs
Market Capitalization$2.23 billion
P/E Ratio-15.66
Dividend YieldN/A

Analyst Ratings

Global Blood Therapeutics (NASDAQ:GBT) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
14 Wall Street analysts have issued ratings and price targets for Global Blood Therapeutics in the last 12 months. Their average twelve-month price target is $86.3571, suggesting that the stock has a possible upside of 99.76%. The high price target for GBT is $150.00 and the low price target for GBT is $61.00. There are currently 1 hold rating and 13 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.932.932.932.92
Ratings Breakdown: 0 Sell Rating(s)
1 Hold Rating(s)
13 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
13 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
13 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
11 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $86.3571$83.1429$82.5714$72.4167
Price Target Upside: 99.76% upside109.74% upside96.60% upside53.43% upside

Global Blood Therapeutics (NASDAQ:GBT) Consensus Price Target History

Price Target History for Global Blood Therapeutics (NASDAQ:GBT)

Global Blood Therapeutics (NASDAQ:GBT) Analyst Ratings History

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
12/4/2018SunTrust BanksBoost Price TargetBuy ➝ Positive$90.00MediumView Rating Details
12/4/2018HC WainwrightSet Price TargetBuy$150.00MediumView Rating Details
12/3/2018William BlairReiterated RatingBuyHighView Rating Details
12/3/2018Cantor FitzgeraldSet Price TargetBuy$96.00HighView Rating Details
12/3/2018OppenheimerSet Price TargetBuy$82.00HighView Rating Details
11/19/2018WedbushReiterated RatingBuy$73.00LowView Rating Details
8/13/2018CowenReiterated RatingBuy$83.00HighView Rating Details
8/6/2018Piper Jaffray CompaniesInitiated CoverageOverweight$80.00LowView Rating Details
8/5/2018JPMorgan Chase & Co.Reiterated RatingBuy$75.00LowView Rating Details
6/28/2018NomuraBoost Price TargetBuy ➝ Buy$91.00 ➝ $109.00HighView Rating Details
6/27/2018Wells Fargo & CoBoost Price TargetOutperform$78.00 ➝ $85.00HighView Rating Details
4/26/2018Needham & Company LLCReiterated RatingBuy$70.00HighView Rating Details
3/21/2018Morgan StanleyDowngradeOverweight ➝ Equal Weight$61.00HighView Rating Details
2/13/2018Janney Montgomery ScottInitiated CoverageBuy ➝ Buy$75.00MediumView Rating Details
3/20/2017Roth CapitalSet Price TargetBuy$47.00LowView Rating Details
3/1/2017InstinetInitiated CoverageBuy ➝ Buy$50.00N/AView Rating Details
(Data available from 12/12/2016 forward)
This page was last updated on 12/12/2018 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.

Yahoo Gemini Pixel